Stockreport

Foghorn® Therapeutics appoints Carl P. Decicco, Ph.D. as Chief Scientific Officer

Denali Therapeutics Inc.  (DNLI) 
Last denali therapeutics inc. earnings: 8/6 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.denalitherapeutics.com
PDF Decicco also to become Venture Partner at Flagship Pioneering CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foghorn® Therapeutics Inc. (Foghorn), a discovere [Read more]